AXS Investments LLC Makes New $84,000 Investment in Aflac Incorporated (NYSE:AFL)

AXS Investments LLC bought a new stake in Aflac Incorporated (NYSE:AFLFree Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 1,210 shares of the financial services provider’s stock, valued at approximately $84,000.

Several other hedge funds and other institutional investors also recently modified their holdings of AFL. Bank Julius Baer & Co. Ltd Zurich boosted its stake in Aflac by 99,608.4% during the 2nd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,691,395,636 shares of the financial services provider’s stock valued at $118,059,415,000 after purchasing an additional 1,689,699,293 shares during the period. BlackRock Inc. boosted its position in shares of Aflac by 0.7% during the first quarter. BlackRock Inc. now owns 42,505,613 shares of the financial services provider’s stock worth $2,742,462,000 after buying an additional 291,800 shares during the period. Geode Capital Management LLC boosted its position in shares of Aflac by 0.9% during the first quarter. Geode Capital Management LLC now owns 11,888,265 shares of the financial services provider’s stock worth $765,297,000 after buying an additional 105,298 shares during the period. Morgan Stanley increased its position in Aflac by 22.9% in the 4th quarter. Morgan Stanley now owns 8,812,956 shares of the financial services provider’s stock valued at $634,004,000 after acquiring an additional 1,640,984 shares during the period. Finally, First Trust Advisors LP raised its stake in Aflac by 71.2% during the 1st quarter. First Trust Advisors LP now owns 6,512,084 shares of the financial services provider’s stock valued at $420,160,000 after acquiring an additional 2,707,608 shares in the last quarter. Institutional investors and hedge funds own 66.75% of the company’s stock.

Aflac Stock Up 0.8 %

AFL stock opened at $81.77 on Monday. Aflac Incorporated has a 1 year low of $60.20 and a 1 year high of $82.71. The company has a fifty day simple moving average of $78.54 and a 200 day simple moving average of $73.37. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.31. The firm has a market cap of $47.78 billion, a PE ratio of 10.77, a PEG ratio of 1.97 and a beta of 0.89.

Aflac (NYSE:AFLGet Free Report) last posted its earnings results on Thursday, November 2nd. The financial services provider reported $1.84 earnings per share for the quarter, topping the consensus estimate of $1.44 by $0.40. The firm had revenue of $4.95 billion during the quarter, compared to analyst estimates of $4.31 billion. Aflac had a return on equity of 17.86% and a net margin of 24.17%. The company’s revenue for the quarter was up 5.2% on a year-over-year basis. During the same period in the previous year, the company earned $1.23 EPS. Sell-side analysts anticipate that Aflac Incorporated will post 6.26 EPS for the current fiscal year.

Aflac Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 1st. Shareholders of record on Wednesday, November 15th will be issued a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a yield of 2.05%. The ex-dividend date of this dividend is Tuesday, November 14th. Aflac’s dividend payout ratio (DPR) is 26.35%.

Analysts Set New Price Targets

Several equities research analysts recently commented on AFL shares. StockNews.com assumed coverage on Aflac in a report on Thursday, October 5th. They set a “hold” rating on the stock. Raymond James raised their price target on shares of Aflac from $77.00 to $83.00 and gave the stock an “outperform” rating in a report on Tuesday, September 26th. Bank of America upped their price objective on shares of Aflac from $79.00 to $86.00 in a research note on Wednesday, August 2nd. Morgan Stanley lifted their target price on shares of Aflac from $75.00 to $80.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 15th. Finally, Citigroup upped their price target on shares of Aflac from $69.00 to $76.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 9th. Seven research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $79.63.

View Our Latest Report on AFL

Insider Activity

In related news, COO Frederick John Crawford sold 100,000 shares of the business’s stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $81.37, for a total transaction of $8,137,000.00. Following the completion of the transaction, the chief operating officer now owns 236,539 shares of the company’s stock, valued at approximately $19,247,178.43. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director Joseph L. Moskowitz sold 500 shares of Aflac stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $76.47, for a total transaction of $38,235.00. Following the sale, the director now directly owns 26,598 shares of the company’s stock, valued at $2,033,949.06. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, COO Frederick John Crawford sold 100,000 shares of the company’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $81.37, for a total value of $8,137,000.00. Following the completion of the transaction, the chief operating officer now directly owns 236,539 shares of the company’s stock, valued at approximately $19,247,178.43. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 162,201 shares of company stock valued at $13,163,404. 0.90% of the stock is owned by insiders.

Aflac Company Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Stories

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.